These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 12052224)

  • 1. Genomics strategies for antifungal drug discovery--from gene discovery to compound screening.
    Willins DA; Kessler M; Walker SS; Reyes GR; Cottarel G
    Curr Pharm Des; 2002; 8(13):1137-54. PubMed ID: 12052224
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Large-scale essential gene identification in Candida albicans and applications to antifungal drug discovery.
    Roemer T; Jiang B; Davison J; Ketela T; Veillette K; Breton A; Tandia F; Linteau A; Sillaots S; Marta C; Martel N; Veronneau S; Lemieux S; Kauffman S; Becker J; Storms R; Boone C; Bussey H
    Mol Microbiol; 2003 Oct; 50(1):167-81. PubMed ID: 14507372
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genomic identification of potential targets unique to Candida albicans for the discovery of antifungal agents.
    Tripathi H; Luqman S; Meena A; Khan F
    Curr Drug Targets; 2014 Jan; 15(1):136-49. PubMed ID: 24102473
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Advances in fungal chemical genomics for the discovery of new antifungal agents.
    Xue A; Robbins N; Cowen LE
    Ann N Y Acad Sci; 2021 Jul; 1496(1):5-22. PubMed ID: 32860238
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Progress in functional genomics approaches to antifungal drug target discovery.
    De Backer MD; Van Dijck P
    Trends Microbiol; 2003 Oct; 11(10):470-8. PubMed ID: 14557030
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chemical-genetic approaches for exploring the mode of action of natural products.
    Lopez A; Parsons AB; Nislow C; Giaever G; Boone C
    Prog Drug Res; 2008; 66():237, 239-71. PubMed ID: 18416308
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Integrated antifungal drug discovery in Candida albicans.
    Sanglard D
    Nat Biotechnol; 2001 Mar; 19(3):212-3. PubMed ID: 11231545
    [No Abstract]   [Full Text] [Related]  

  • 8. The Toxicity of a Novel Antifungal Compound Is Modulated by Endoplasmic Reticulum-Associated Protein Degradation Components.
    Raj S; Krishnan K; Askew DS; Helynck O; Suzanne P; Lesnard A; Rault S; Zeidler U; d'Enfert C; Latgé JP; Munier-Lehmann H; Saveanu C
    Antimicrob Agents Chemother; 2015 Dec; 60(3):1438-49. PubMed ID: 26666917
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genomic and genetic approaches for the identification of antifungal drug targets.
    Agarwal AK; Xu T; Jacob MR; Feng Q; Li XC; Walker LA; Clark AM
    Infect Disord Drug Targets; 2008 Mar; 8(1):2-15. PubMed ID: 18473903
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gene Essentiality Analyzed by
    Segal ES; Gritsenko V; Levitan A; Yadav B; Dror N; Steenwyk JL; Silberberg Y; Mielich K; Rokas A; Gow NAR; Kunze R; Sharan R; Berman J
    mBio; 2018 Oct; 9(5):. PubMed ID: 30377286
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of essential genes in the human fungal pathogen Aspergillus fumigatus by transposon mutagenesis.
    Firon A; Villalba F; Beffa R; D'Enfert C
    Eukaryot Cell; 2003 Apr; 2(2):247-55. PubMed ID: 12684374
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of Homologous Resistance Mutations from Pathogenic Yeast on Saccharomyces cerevisiae Lanosterol 14α-Demethylase.
    Sagatova AA; Keniya MV; Tyndall JDA; Monk BC
    Antimicrob Agents Chemother; 2018 Mar; 62(3):. PubMed ID: 29263059
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genomic Approaches to Antifungal Drug Target Identification and Validation.
    Robbins N; Cowen LE
    Annu Rev Microbiol; 2022 Sep; 76():369-388. PubMed ID: 35650665
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Conserved fungal genes as potential targets for broad-spectrum antifungal drug discovery.
    Liu M; Healy MD; Dougherty BA; Esposito KM; Maurice TC; Mazzucco CE; Bruccoleri RE; Davison DB; Frosco M; Barrett JF; Wang YK
    Eukaryot Cell; 2006 Apr; 5(4):638-49. PubMed ID: 16607011
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Crystal Structure of the New Investigational Drug Candidate VT-1598 in Complex with Aspergillus fumigatus Sterol 14α-Demethylase Provides Insights into Its Broad-Spectrum Antifungal Activity.
    Hargrove TY; Garvey EP; Hoekstra WJ; Yates CM; Wawrzak Z; Rachakonda G; Villalta F; Lepesheva GI
    Antimicrob Agents Chemother; 2017 Jul; 61(7):. PubMed ID: 28461309
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A survey of yeast genomic assays for drug and target discovery.
    Smith AM; Ammar R; Nislow C; Giaever G
    Pharmacol Ther; 2010 Aug; 127(2):156-64. PubMed ID: 20546776
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The use of direct cDNA selection to rapidly and effectively identify genes in the fungus Aspergillus fumigatus.
    Kessler MM; Willins DA; Zeng Q; Del Mastro RG; Cook R; Doucette-Stamm L; Lee H; Caron A; McClanahan TK; Wang L; Greene J; Hare RS; Cottarel G; Shimer GH
    Fungal Genet Biol; 2002 Jun; 36(1):59-70. PubMed ID: 12051895
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Yeast genomics and proteomics in drug discovery and target validation.
    Parsons AB; Geyer R; Hughes TR; Boone C
    Prog Cell Cycle Res; 2003; 5():159-66. PubMed ID: 14593709
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Yeast and drug discovery.
    Hughes TR
    Funct Integr Genomics; 2002 Sep; 2(4-5):199-211. PubMed ID: 12192593
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel strategies in antifungal lead discovery.
    Jiang B; Bussey H; Roemer T
    Curr Opin Microbiol; 2002 Oct; 5(5):466-71. PubMed ID: 12354552
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.